These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27467278)

  • 21. Alkaline phosphatase and prognosis in patients with coronary artery disease.
    Ndrepepa G; Xhepa E; Braun S; Cassese S; Fusaro M; Schunkert H; Kastrati A
    Eur J Clin Invest; 2017 May; 47(5):378-387. PubMed ID: 28369867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.
    Noordzij M; Korevaar JC; Boeschoten EW; Dekker FW; Bos WJ; Krediet RT;
    Am J Kidney Dis; 2005 Nov; 46(5):925-32. PubMed ID: 16253734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerostin quo vadis? - is this a useful long-term mortality parameter in prevalent hemodialysis patients?
    Nowak A; Artunc F; Serra AL; Pollock E; Krayenbühl PA; Müller C; Friedrich B
    Kidney Blood Press Res; 2015; 40(3):266-76. PubMed ID: 25997652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined alkaline phosphatase and phosphorus levels as a predictor of mortality in maintenance hemodialysis patients.
    Chang JF; Feng YF; Peng YS; Hsu SP; Pai MF; Chen HY; Wu HY; Yang JY
    Medicine (Baltimore); 2014 Oct; 93(18):e106. PubMed ID: 25319440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.
    Merle E; Roth H; London GM; Jean G; Hannedouche T; Bouchet JL; Drüeke T; Fouque D; Daugas E;
    Kidney Int; 2016 Mar; 89(3):666-74. PubMed ID: 26880460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.
    Kalantar-Zadeh K; Kuwae N; Regidor DL; Kovesdy CP; Kilpatrick RD; Shinaberger CS; McAllister CJ; Budoff MJ; Salusky IB; Kopple JD
    Kidney Int; 2006 Aug; 70(4):771-80. PubMed ID: 16820797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization.
    Abramowitz M; Muntner P; Coco M; Southern W; Lotwin I; Hostetter TH; Melamed ML
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1064-71. PubMed ID: 20378645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Bradbury BD; Fissell RB; Albert JM; Anthony MS; Critchlow CW; Pisoni RL; Port FK; Gillespie BW
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):89-99. PubMed ID: 17699392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-hospital mortality risk estimation in patients with acute nonvariceal upper gastrointestinal bleeding undergoing hemodialysis: a retrospective cohort study.
    Weng SC; Shu KH; Tarng DC; Tang YJ; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Sheu WH; Wu MJ
    Ren Fail; 2013; 35(2):243-8. PubMed ID: 23336331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between serum urea and mortality of hemodialysis patients.
    Stosovic M; Stanojevic M; Simic-Ogrizovic S; Jovanovic D; Djukanovic Lj
    Ren Fail; 2009; 31(5):335-40. PubMed ID: 19839831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study.
    Palmer SC; Ruospo M; Wong G; Craig JC; Petruzzi M; De Benedittis M; Ford P; Johnson DW; Tonelli M; Natale P; Saglimbene V; Pellegrini F; Celia E; Gelfman R; Leal MR; Torok M; Stroumza P; Bednarek-Skublewska A; Dulawa J; Frantzen L; Ferrari JN; Del Castillo D; Bernat AG; Hegbrant J; Wollheim C; Gargano L; Bots CP; Strippoli GF;
    Am J Kidney Dis; 2015 Oct; 66(4):666-76. PubMed ID: 26120038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal amyloidosis is associated with increased mortality in hemodialysis patients.
    Sengul S; Arat Z; Ozdemir FN
    Artif Organs; 2004 Sep; 28(9):846-52. PubMed ID: 15320948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.
    Regidor DL; Kovesdy CP; Mehrotra R; Rambod M; Jing J; McAllister CJ; Van Wyck D; Kopple JD; Kalantar-Zadeh K
    J Am Soc Nephrol; 2008 Nov; 19(11):2193-203. PubMed ID: 18667733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
    Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomagnesemia and Mortality in Incident Hemodialysis Patients.
    Li L; Streja E; Rhee CM; Mehrotra R; Soohoo M; Brunelli SM; Kovesdy CP; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Dec; 66(6):1047-55. PubMed ID: 26184377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis.
    Nakagawa N; Matsuki M; Yao N; Hirayama T; Ishida H; Kikuchi K; Hasebe N
    Ther Apher Dial; 2015 Feb; 19(1):30-9. PubMed ID: 25196142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional Status and Mortality Predictability for Time-Varying Serum Alkaline Phosphatase in Hemodialysis Patients: A Longitudinal Study.
    Beberashvili I; Samogalska O; Azar A; Stav K; Efrati S
    J Ren Nutr; 2020 Sep; 30(5):452-461. PubMed ID: 31980325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
    Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
    Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.
    deFilippi C; Wasserman S; Rosanio S; Tiblier E; Sperger H; Tocchi M; Christenson R; Uretsky B; Smiley M; Gold J; Muniz H; Badalamenti J; Herzog C; Henrich W
    JAMA; 2003 Jul; 290(3):353-9. PubMed ID: 12865376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.